alendronate

(redirected from Binosto)
Also found in: Thesaurus, Medical.

a·len·dro·nate

 (ə-lĕn′drə-nāt′)
n.
A bisphosphonate drug, C4H13NO7P2, that inhibits bone resorption and is used in the form of its sodium salt to treat and prevent osteoporosis in postmenopausal women.

[Probably a(mino) + (buty)l(id)en(e), one of its constituents (butyl + -id(e) + -ene) + (hy)dr(oxy) + (bisphosph)onate.]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.alendronate - a tablet (trade name Fosamax) prescribed to prevent or treat osteoporosis in women after menopausealendronate - a tablet (trade name Fosamax) prescribed to prevent or treat osteoporosis in women after menopause
medicament, medication, medicinal drug, medicine - (medicine) something that treats or prevents or alleviates the symptoms of disease
Translations

alendronate, alendronate sodium

(USAN), alendronic acid (INN) n alendronato, alendronato sódico, ácido alendrónico (INN)
References in periodicals archive ?
The most commonly used bisphosphonate was alendronate (Fosamax, Binosto), used by 72%, followed by zoledronic acid (Reclast, Zometa), used by 16%.
Alendronate sodium (Fosamax, Binosto), the first approved agent for the prevention and treatment of postmenopausal osteoporosis, is considered the gold standard of therapy for this disease.
Food and Drug Administration approved the buffered form of the bisphosphonate drug alendronate sodium (Binosto) in October 2012.